A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
about
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's diseaseGlucocerebrosidase is shaking up the synucleinopathiesGenetics Underlying Atypical Parkinsonism and Related Neurodegenerative DisordersGlucocerebrosidase and Parkinson disease: Recent advancesGenetic markers in biological fluids for aging-related major neurocognitive disorderReducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C MiceParkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritanceMitochondrial dysfunction associated with glucocerebrosidase deficiencyAmbroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cellsTool compounds robustly increase turnover of an artificial substrate by glucocerebrosidase in human brain lysatesNeuropsychiatric characteristics of GBA-associated Parkinson disease.Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.Predicting parkinsonism: new opportunities from Gaucher disease.Induced pluripotent stem cell models of lysosomal storage disorders.Multiple pathogenic proteins implicated in neuronopathic Gaucher disease miceNext generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.Disease variants in genomes of 44 centenarians.The pallidopyramidal syndromes: nosology, aetiology and pathogenesis.UPDATE ON DEMENTIA WITH LEWY BODIES.Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.Glucocerebrosidase mutations in primary parkinsonismLewy body dementias.Structural features of membrane-bound glucocerebrosidase and α-synuclein probed by neutron reflectometry and fluorescence spectroscopy.Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.Cognition in movement disorders: where can we hope to be in ten years?Variants associated with Gaucher disease in multiple system atrophy.Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.A novel common variant in DCST2 is associated with length in early life and height in adulthoodGlucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein.Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease.New macrophage models of Gaucher disease offer new tools for drug developmentLysosomal Enzyme Glucocerebrosidase Protects against Aβ1-42 Oligomer-Induced Neurotoxicity.Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregatesER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.Clinical course and prognosis in patients with Gaucher disease and parkinsonismCharacterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2.A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
P2860
Q24324577-6E581523-BFED-40EA-83C2-E4D1815AB962Q24337392-AF153474-C5E4-4313-ADE9-F2491A4B3DEAQ26779001-CCFCE9D6-792D-4832-8C3A-BF1D96116039Q27005669-B20023BC-2BE9-4D93-AF28-C825F4716C7BQ27027348-65276F6D-31D9-4E0B-A42D-A26E3384647BQ27300108-9984E6A6-C2E4-497F-8666-48CE1E0EF2F0Q27686837-975FFE8C-FD5E-4105-9A9A-73CDE79C6C8FQ28077356-9C2520EB-ED1D-4197-9111-68EAF92E306FQ28115678-7F8F8765-226F-4729-B15B-A080FE8C0529Q28308084-C7F1DCBB-3405-48CA-9413-1C3D2E6A31FCQ28543988-E2E4C129-EC84-41FA-A239-BBF774D1F8E5Q30275630-BE5584B5-6D7A-42E2-8E32-448FBEB19D07Q30367337-CEDA1927-985F-401D-A313-C0BA0E2BA0F6Q30409165-C469596C-2CDC-4E51-B6BA-8B486AA08536Q30432618-7F23EE33-D671-48B7-8A18-E9D10D3B1DD1Q33830512-9C902F3F-2F22-4A40-AEE2-56B911097C55Q33847578-DD6255C0-4723-4E6F-B40C-972063217C79Q34222296-78A50517-4B7E-4298-A376-E50840FC0713Q34311136-8C994690-D163-42A2-BD73-C4943806B297Q34336776-4A2CA532-D7EE-4265-9A45-C906AFA5D2ADQ34450376-FF29E347-BC28-4DC1-B868-A869895E3D57Q34463167-55157A71-DB91-4153-ABCB-4610FF3846C0Q34481921-343D304D-32FE-4A62-9B04-20CAC46FDD63Q34491177-E3B7B852-5EE0-4A3B-A0C4-E63BC81C2CD4Q34502646-2B0F7DD0-EA99-47E0-85B9-E448B86DC071Q34964902-725AA000-4D8E-4F20-B8DE-D74E90B80C8FQ35079812-1C9E5EAC-D798-4640-A5D2-64CB689B982FQ35211553-27E367C8-119F-467A-BF3F-931CD9112245Q35469633-7BF85A95-DF9B-4929-9F47-98898BB4B30AQ35596071-C4C1E2A6-72A6-474B-8F15-15D4F4E62EECQ35661744-30973CFD-1B10-40DB-93EB-BC4C48D27243Q35674483-972D1BFF-6904-48BF-92CF-62473EA51901Q35686212-396CFCB8-9C06-458C-8952-5A1928936DD8Q35747464-132CFD9D-3C3C-4433-AC0C-AE6C11A7C176Q35858682-3DA28768-C910-45B4-B4C9-0CD10435FB4FQ36246469-871D0A8F-D1CF-49C0-86FC-A4F02D4EAD01Q36678823-BE6BB27A-121C-45B4-9B88-00DD7A1A474CQ36794066-00B99E0B-0C11-4EFB-9748-B0E4CE5BB5D4Q36802483-40C6928B-492D-4DA2-A58C-FC293BA1B759Q37096051-E694384F-E2B7-4BB0-8F33-EF02935CA701
P2860
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
@en
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
@nl
type
label
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
@en
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
@nl
prefLabel
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
@en
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
@nl
P2093
P2860
P50
P1433
P1476
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
@en
P2093
Benoit I Giasson
Bernardino Ghetti
Charles Duyckaerts
Claudia Landazabal
David Crosiers
David M A Mann
Ellen Sidransky
Elvira Valeria De Marco
Grisel Lopez
Howard I Hurtig
P2860
P304
P356
10.1001/JAMANEUROL.2013.1925
P407
P50
P577
2013-06-01T00:00:00Z